Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bernstein Karen
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Duncan Barbara Gayle
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Friedman Bart
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fitzgerald Kevin Joseph
Ovid Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(0%),Oleg Nodelman(0%), etc.
Ovid Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(5.4%),BVF Inc.(5.4%), etc.
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ALEXANDER MARGARET A.
Ovid Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer ALEXANDER MARGARET A.
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rona Jeffrey A
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEVIN JEREMY M
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tardio Jason
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rona Jeffrey A
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Poole Robert Michael
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Perone Thomas Michael
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEVIN JEREMY M
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Friedman Bart
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fitzgerald Kevin Joseph
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Duncan Barbara Gayle
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bernstein Karen
Ovid Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jeremy M. Levin(9.4%)